Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 12Gastrointestinal 10Gynecologic 9Genitourinary 4Other hematologic neoplasm 3Lymphoid 3CNS 3Plasma cell 1Other solid neoplasm 1Other neoplasm 1Myeloid 1Classical hematology 1

Conditions

Histiocytosis, Non-Langerhans-Cell 1Histiocytosis, Langerhans-Cell 1Castleman Disease 1

Interventions

Cyclophosphamide 21fludarabine phosphate 15Cyclosporine 13Antilymphocyte Serum 13Peripheral Blood Stem Cell Transplantation 12Busulfan 12Whole-Body Irradiation 11Mycophenolic Acid 10Filgrastim 8fludarabine 7Methotrexate 7Melphalan 7Therapeutics 5Radiotherapy 5Cytarabine 5Blood Specimen Collection 5Tacrolimus 4Psychiatric Rehabilitation 4Methylprednisolone 4Cord Blood Stem Cell Transplantation 4thymoglobulin 3Stem Cell Transplantation 3Palliative Care 3Imatinib Mesylate 3Granulocyte Colony-Stimulating Factor 3Flow Cytometry 3Dexamethasone 3Behavior Therapy 3Aprepitant 3sargramostim 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Genetic Testing × Myeloid × Clear all
NCT05028621 2026-05-07

Molecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms and Castleman Disease

Case Comprehensive Cancer Center

Phase NA Suspended
135 enrolled
LymphoidMyeloid

Castleman Disease, Histiocytosis, Langerhans-Cell, Histiocytosis, Non-Langerhans-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡